期刊文献+

主动脉内球囊反搏临床应用时机的选择与效果分析 被引量:31

Selecting of opportunity and application effect of Intra-aortic Balloon Pump for Patients with Critical Heart disease
暂未订购
导出
摘要 目的:探讨主动脉内球囊反搏(IABP)在危重心脏病患者中应用时机的选择对治疗效果的影响。方法:分析48例危重心脏病患者并发心源性休克或低心排血量综合征(低心排)时应用IABP辅助治疗的临床效果以及影响预后的因素。结果:48例患者在应用IABP后血流动力学均有一定的改善;其中早期安装IABP的31例患者,死亡3例,病死率9.7%;手术或介入治疗后常规药物治疗(晚期)12~24 h后安装IABP的17例患者中有8例死亡,病死率47.1%。结论:IABP是一种简单有效的循环辅助手段,对危重心脏病患者改善血流动力学有一定效果,但安装时机的选择对治疗效果有明显的影响。IABP的安装应宁早勿晚。 Objective: To investigate the application opportunity of intra-aortic balloon pump (IABP)for patients of severe heart disease and the application opportunity how to effect therapeutic efficacy for these patients. Method:To analyze the adjunctive therapy clinical effect and an influence prognostic factor for 48 patients with cardiogenic shock or low cardiac output syndrome who undergone IABP. ReSult : The hemodynamics of patients have determinate amelioration undergone IABP to treat; There were 31 patients In the first time were used IABP to support, 3 cases died, death rate was 9.7% (3/31);After operation on heart or interventional therapy, there were 17 patients undergone routine method drug treatment for 12-24 h weren't effect and then to insert IABP, 8 died, the death rate was47.1%(8/17). Conclusion: IABP is a simple available circulation assist device and it is highly effective for patients of critical heart disease to improve bemodynamics; But installation opportunity have evident effect for therapeutic efficacy. The application for IABP must be early don't late.
出处 《心肺血管病杂志》 CAS 2009年第4期223-225,共3页 Journal of Cardiovascular and Pulmonary Diseases
基金 天津市科委计划课题(编号:06YFSZSF01500)
关键词 主动脉内球囊反搏 心脏外科手术 急性心肌梗死 低心排血量综合征 Intra-aortic balloon pump Operation on heart Acute myocardial infarction Low cardiac output syndrome
  • 相关文献

参考文献12

二级参考文献36

  • 1[1]Urban PM,Freedman RJ,Ohman EM,et al.In-hospital mortality associated with the use of intra-aortic balloon counterpulsation[J].Am J Cardiol,2004,94(2):181-185.
  • 2[2]Amado LC,Kraitchman DL,Gerber BL,et al.Reduction of"no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study[J].J Am Coll Cardiol,2004,43(7):1291-1298.
  • 3[3]Briguori C,Sarais C,Pagnotta P,et al.Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty[J].Am Heart J,2003,145(4):700-707.
  • 4[4]Gold HK,Leinbach RC,Buckley MJ,et al.Refractory angina pectoris:follow-up after intraaortic balloon pumping and surgery[J].Circulation,1976,54(6 Suppl):Ⅲ41-Ⅲ46.
  • 5[5]La VecchiaL,Favero L,Martini M,et al.Systematic coronary stenting after failed thrombolysis in high-risk patients with acute myocardial infarction:procedural results and long-term follow-up[J].Coron Artery Dis,2003,14 (5):395-400.
  • 6[6]Berger PB,Tuttle RH,Holmes DR,et al.One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock,and its relation to early revascularization:results from the GUSTO-Ⅰ trial[J].Circulation,1999,99(7):873-878.
  • 7[7]Menon V,Fincke R.Cardiogenic shock:a summary of the randomized SHOCK trial[J].Congest Heart Fail,2003,9(1):35-39.
  • 8[8]Menon V,Hochman JS,Stebbins A,et al.Lack of progress in cardiogenic shock:lessons from the GUSTO trials[J].Eur Heart J,2000,21 (23):1928-1936.
  • 9[9]Sanborn TA,Sleeper LA,Bates ER,et al.Impact of thrombolysis,intra-aortic balloon pump counterpulsation,and their combination in cardiogenic shock complicating acute myocardial infarction:a report from the SHOCK Trial Registry.Should we emergently revascularize Occluded Coronaries for cardiogenic shock[J].J Am Coll Cardiol,2000,36 (3Suppl A):1123-1129.
  • 10[10]French JK,Feldman HA,Assmann SF,et al.Influence of thrombolytic therapy,with or without intra-aortic balloon counterpulsation,on 12-month survival in the SHOCK trial[J].Am Heart J,2003,46(5):804-810.

共引文献73

同被引文献190

引证文献31

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部